What changed: Grade 3 well-differentiated neuroendocrine tumour

Every dated change on the records linked to Grade 3 well-differentiated neuroendocrine tumour, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.